Combination peroxisome proliferator-activated receptor γ and α agonist treatment in Type 2 diabetes prevents the beneficial pioglitazone effect on liver fat content

✍ Scribed by R. Balasubramanian; J. Gerrard; C. Dalla Man; M. J. Firbank; A. Lane; P. T. English; C. Cobelli; R. Taylor

• Book ID: 110926867
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 204 KB
• Volume: 27
• Category: Article
• ISSN: 0742-3071
• DOI: 10.1111/j.1464-5491.2009.02906.x